蝨子治疗市场规模、份额和成长分析(按产品类型、剂型、给药途径、症状、剂量形式、分销管道和地区划分)—产业预测(2026-2033 年)
市场调查报告书
商品编码
1897896

蝨子治疗市场规模、份额和成长分析(按产品类型、剂型、给药途径、症状、剂量形式、分销管道和地区划分)—产业预测(2026-2033 年)

Lice Treatment Market Size, Share, and Growth Analysis, By Product Type (OTC products, Prescription medications), By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 193 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,全球蝨子治疗市场规模将达到 23.5 亿美元,到 2025 年将达到 25.1 亿美元,到 2033 年将达到 42.9 亿美元,预测期(2026-2033 年)的复合年增长率为 6.9%。

由于虱病不断上升,全球除蝨市场预计将迎来显着增长,尤其是在学校人满为患和社区人际交往密切等因素的影响下。非处方药的便利性和产品配方的进步正在推动市场进一步成长。此外,人们对传统杀虫剂类产品神经毒性的担忧也产生了重大影响,促使消费者对天然无毒的治疗方法产生需求。线上零售平台的兴起也提高了治疗方法的可及性,使市场参与者受益。然而,蝨子对化学治疗的抗药性日益增强、有害的副作用、低收入地区获取途径有限以及与蝨子感染相关的社会污名等挑战,可能会在短期内阻碍市场渗透和成长。

全球蝨子治疗市场驱动因素

全球除蝨产品市场成长的主要驱动力在于治疗配方方面的创新,这些创新提高了治疗效果和使用者安全性。现代产品不含杀虫剂,采用硅酮溶液,以物理方式固定蝨子,最大限度地减少对神经毒素的依赖,并有效解决抗药性问题。这些现代疗法无味、无刺激性,且所需时间更短,显着提升了使用者体验。这些进步提高了消费者的信任度和满意度,从而增加了重复购买率,并为除蝨产品市场带来了光明的前景。

全球蝨子治疗市场面临的限制因素

由于蝨子对传统治疗方法的抗药性日益增强,全球除蝨市场正面临严峻挑战。过度使用以往备受信赖的化学製剂,例如Permethrin和除虫菊酯,降低了其疗效,导致治疗失败。这种抗药性不仅令消费者感到失望,也削弱了消费者对知名品牌的信任,最终影响了復购率。此外,对多种化学疗法具有抗药性的「超级蝨」的出现,进一步加剧了市场挑战。因此,市场对非化学替代疗法的需求日益增长,这阻碍了除蝨产业的成长。

全球蝨子治疗市场趋势

全球除蝨市场正经历着向预防保健的显着转变,消费者越来越重视采取积极措施预防蝨子感染。这一发展趋势的特点是,消费者对预防性产品的需求不断增长,例如添加了迷迭香和尤加利等具有天然驱蝨功效的精油的特製洗髮精、喷雾剂和梳子。家长和教育机构正在采用这些预防措施,以确保创造无蝨环境,从而将市场范围从单纯的被动治疗扩展到更全面的预防。这种对产品长期使用的重视反映了人们对蝨子预防意识的不断提高,最终将改变消费者的行为并推动产业创新。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球蝨子治疗市场规模(按产品类型和复合年增长率划分)(2026-2033 年)

  • 非处方药
    • Permethrin
    • 除虫菊酯
    • 其他非处方药
  • 处方药
    • 伊维菌素
    • 多杀菌素
    • Malathion
    • 其他处方药

全球蝨子治疗市场规模(按类型及复合年增长率划分)(2026-2033 年)

  • 品牌产品
  • 非专利的

全球蝨子治疗市场规模(依给药途径及复合年增长率划分)(2026-2033 年)

  • 口服
  • 外用

全球蝨子治疗市场规模(按症状和复合年增长率划分)(2026-2033 年)

  • 头蝨
  • 体蝨
  • 阴蝨

全球蝨子治疗市场规模(依剂型及复合年增长率划分)(2026-2033 年)

  • 药片
  • 洗髮精
  • 洗剂
  • 奶油
  • 其他剂型

全球蝨子治疗市场规模(依分销管道划分)及复合年增长率(2026-2033 年)

  • 医院药房
  • 零售药房
  • 其他分销管道

全球蝨子治疗市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Johnson & Johnson Services, Inc.(USA)
  • Reckitt Benckiser Group plc(UK)
  • Perrigo Company plc(Ireland)
  • Prestige Consumer Healthcare Inc.(USA)
  • Sanofi SA(France)
  • GlaxoSmithKline(GSK)plc(UK)
  • Teva Pharmaceutical Industries Ltd.(Israel)
  • Pfizer Inc.(USA)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Sun Pharmaceutical Industries Ltd.(India)
  • ParaPRO LLC.(USA)
  • Alliance Pharma PLC(UK)
  • Arbor Pharmaceuticals, LLC.(USA)
  • Oystershell Consumer Health(Belgium)
  • Taro Pharmaceuticals(Canada)
  • ICB PHARMA(Poland)
  • Lice Clinics of America(USA)

结论与建议

简介目录
Product Code: SQMIG35D2312

Global Lice Treatment Market size was valued at USD 2.35 Billion in 2024 and is poised to grow from USD 2.51 Billion in 2025 to USD 4.29 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).

The global lice treatment market is poised for significant growth driven by an increasing incidence of lice infestations, particularly due to factors like overcrowded schools and close community interactions. The convenience of over-the-counter treatments and advancements in product formulations further enhance market opportunities. Additionally, there is a rising demand for natural and non-toxic treatment options, largely influenced by concerns over the neurotoxicity associated with conventional pesticide-based products. The growth of online retail platforms has also improved accessibility of treatments, benefitting market players. However, challenges such as the rising resistance of lice to chemical treatments, adverse side effects, limited access in low-income regions, and social stigma surrounding infestations may hinder market penetration and growth in the near future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lice Treatment Market Segments Analysis

Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lice Treatment Market

The growth of the Global Lice Treatment market is significantly propelled by innovations in treatment formulations that enhance both efficacy and user safety. Modern products now feature non-pesticide and silicone-based solutions that immobilize lice physically, minimizing the reliance on neurotoxins and addressing resistance issues. These contemporary treatments are designed to be odorless and less irritating, while also requiring shorter application times, which greatly improves the overall user experience. As a result of these advancements, consumers develop greater trust and satisfaction, leading to increased repeat purchases and a positive outlook for the lice treatment market moving forward.

Restraints in the Global Lice Treatment Market

The Global Lice Treatment market faces significant challenges due to the increasing resistance of lice to traditional treatments. Previously reliable chemical agents such as permethrin and pyrethrin have seen diminished effectiveness due to over-application, leading to instances of treatment failure. This resistance not only frustrates consumers but also erodes trust in established brands, ultimately affecting repeat purchases. Additionally, the emergence of "super lice," which resist multiple chemical treatments, compounds the difficulties within the market. Consequently, there is a growing demand for alternative non-chemical solutions, which has impeded the growth of the lice treatment industry.

Market Trends of the Global Lice Treatment Market

The Global Lice Treatment market is witnessing a notable shift toward preventive care, as consumers increasingly prioritize proactive strategies to thwart lice infestations. This evolving trend is characterized by heightened demand for preventive products, including specially formulated shampoos, sprays, and combs infused with natural lice-repelling essential oils like rosemary and eucalyptus. Parents and educational institutions are adopting these preventive measures to ensure a lice-free environment, thereby broadening the market's scope beyond mere reactive treatments. This emphasis on long-term product usage reflects a growing awareness of lice prevention, ultimately transforming consumer behavior and driving innovation within the industry.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Lice Treatment Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • OTC products
    • Permethrin
    • Pyrethrin
    • Other OTC products
  • Prescription medications
    • Ivermectin
    • Spinosad
    • Malathion
    • Other prescription medications

Global Lice Treatment Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Branded
  • Generic

Global Lice Treatment Market Size by Route of Administration & CAGR (2026-2033)

  • Market Overview
  • Oral
  • Topical

Global Lice Treatment Market Size by Condition & CAGR (2026-2033)

  • Market Overview
  • Pediculosis capitis
  • Pediculosis corporis
  • Pediculosis pubis

Global Lice Treatment Market Size by Dosage Form & CAGR (2026-2033)

  • Market Overview
  • Tablets
  • Shampoos
  • Lotions
  • Cream
  • Other dosage forms

Global Lice Treatment Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Hospital pharmacies
  • Retail pharmacies
  • Other distribution channels

Global Lice Treatment Market Size & CAGR (2026-2033)

  • North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
    • US
    • Canada
  • Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Johnson & Johnson Services, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reckitt Benckiser Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Prestige Consumer Healthcare Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline (GSK) plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd. (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ParaPRO LLC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alliance Pharma PLC (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Arbor Pharmaceuticals, LLC. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oystershell Consumer Health (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Taro Pharmaceuticals (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICB PHARMA (Poland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lice Clinics of America (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations